Literature DB >> 7613445

Malaria prophylaxis. Mefloquine toxicity should limit its use to treatment alone.

G C Cook.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613445      PMCID: PMC2550242          DOI: 10.1136/bmj.311.6998.190b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Neuropsychiatric side effects after the use of mefloquine.

Authors:  T Weinke; M Trautmann; T Held; G Weber; D Eichenlaub; K Fleischer; W Kern; H D Pohle
Journal:  Am J Trop Med Hyg       Date:  1991-07       Impact factor: 2.345

2.  Malaria prophylaxis: guidelines for travellers from Britain. Malaria Reference Laboratory of the Public Health Laboratory Service, London.

Authors:  D J Bradley; D C Warhurst
Journal:  BMJ       Date:  1995-03-18

3.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

4.  Long-term malaria prophylaxis with weekly mefloquine.

Authors:  H O Lobel; M Miani; T Eng; K W Bernard; A W Hightower; C C Campbell
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

5.  Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.

Authors:  J C Wetsteyn; A de Geus
Journal:  BMJ       Date:  1993-10-23
  5 in total
  5 in total

1.  Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.

Authors:  E L Corbett; J P Doherty; R H Behrens
Journal:  BMJ       Date:  1996-12-14

Review 2.  Antimalarial chemoprophylaxis in infants and children.

Authors:  M H Kramer; H O Lobel
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains.

Authors:  Geoffrey S Dow; Michael L Koenig; Lesley Wolf; Lucia Gerena; Miriam Lopez-Sanchez; Thomas H Hudson; Apurba K Bhattacharjee
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 4.  WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers.

Authors:  A M J Croft; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 5.  Complex Membrane Channel Blockade: A Unifying Hypothesis for the Prodromal and Acute Neuropsychiatric Sequelae Resulting from Exposure to the Antimalarial Drug Mefloquine.

Authors:  Jane C Quinn
Journal:  J Parasitol Res       Date:  2015-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.